Back to mobile site

BioSpecifics (BSTC) Submits BLA for XIAFLEX as Peyronie's Treatment

November 7, 2012 5:20 PM EST Send to a Friend
BioSpecifics Technologies Corp. (NASDAQ: BSTC) announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login